Product Information
DEXILANT DR 30 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.8434 per EA under NDC 64764017130. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the dexlansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764017130
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA022287On Market Since
4/12/2010
Pharmacological Classes
Price Statistics
The NADAC for DEXILANT DR 30 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8434 per EA |
|---|---|
| All-time high | $9.8767 (Jun 14, 2023) |
| All-time low | $5.3833 (Nov 28, 2013) |
| 52-week high | $9.8529 |
| 52-week low | $9.8341 |
| Median price | $9.2959 |
| Average price | $8.7509 |
| Largest weekly change | +9.9% (Jun 10, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXILANT DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DEXILANT DR 30 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $9.8434 per EA (NDC 64764017130), effective Jun 24, 2026.
How has the price of DEXILANT DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DEXILANT DR 30 MG CAPSULE has risen 82.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXILANT DR 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DEXILANT DR 30 MG CAPSULE has ranged from a low of $5.3833 (Nov 28, 2013) to a high of $9.8767 (Jun 14, 2023), with a median of $9.2959 per EA.
Are there cheaper alternatives to DEXILANT DR 30 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXLANSOPRAZOLE DR 30 MG CAP, is $4.1649 per EA — about 58% below DEXILANT DR 30 MG CAPSULE.
Who manufactures DEXILANT DR 30 MG CAPSULE?
DEXILANT DR 30 MG CAPSULE (NDC 64764017130) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification